Lion Point Capital, LP Mirum Pharmaceuticals, Inc. Transaction History
Lion Point Capital, LP
- $37.2 Million
- Q3 2024
A detailed history of Lion Point Capital, LP transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Lion Point Capital, LP holds 45,000 shares of MIRM stock, worth $2.2 Million. This represents 4.71% of its overall portfolio holdings.
Number of Shares
45,000
Previous 45,000
-0.0%
Holding current value
$2.2 Million
Previous $1.54 Million
14.11%
% of portfolio
4.71%
Previous 3.29%
Shares
4 transactions
Others Institutions Holding MIRM
# of Institutions
193Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$321 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$219 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$168 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$158 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$150 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.8B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...